GH Axis Research
Studied for its interaction with growth hormone secretion pathways.
Overview
CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog studied for its role in stimulating endogenous growth hormone secretion pathways.
Suria's CJC-1295 is synthesized to high purity and independently verified prior to release, supporting consistent, well-documented GH-axis research.
Research Use Only. Not for human or veterinary use.
Specifications
Third-Party Testing
Available third-party analytical documentation for CJC-1295 can be reviewed for applicable batches through Suria's Batch Documentation system. We believe documentation should be held to the same standard as the research it supports.
Certificates of Analysis will be available at time of launch.
Research Highlights
Studied for its interaction with growth hormone secretion pathways.
A frequent focus of lean-mass and body-composition research models.
Studied for a targeted mechanism of action within the GH secretagogue class.
Consistent, well-documented starting material for endocrine pathway research.
Storage
Store at −20°C, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the recommended window for your protocol.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation